ATXS · Categories · Form 4

ATXS - SEC Form 4 insider transactions

Astria Therapeutics Inc. (ATXS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ATXS

• 138d
  Director Violin Jonathan returned 263,321 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Chief Medical Officer Morabito Christopher

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  CEO and President Milne Jill C. returned 4,377 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Chief Business Officer Matthews Andrea

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Director Lapointe Anthony Gregg

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  Chief Commercial Officer Komjathy Andrew returned 100 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Director Kishbauch Michael D

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Chief Legal Officer Harshbarger Benjamin

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Director Cole Hugh M

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Chief Financial Officer Clauser Noah

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Director Callori Fred

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Director Beck Joanne T.

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Director Bate Kenneth

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 138d
  SEC Form 4 filed by Director Agarwal Sunil

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 363d
  SEC Form 4 filed by Director Agarwal Sunil

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 363d
  SEC Form 4 filed by Director Bate Kenneth

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 363d
  SEC Form 4 filed by Director Cole Hugh M

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 363d
  SEC Form 4 filed by Director Kishbauch Michael D

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 363d
  SEC Form 4 filed by Director Lapointe Anthony Gregg

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 363d
  SEC Form 4 filed by Director Violin Jonathan

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 363d
  SEC Form 4 filed by Director Beck Joanne T.

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 363d
  SEC Form 4 filed by Director Callori Fred

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 443d
  SEC Form 4 filed by CEO and President Milne Jill C.

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 443d
  SEC Form 4 filed by Chief Business Officer Matthews Andrea

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 443d
  SEC Form 4 filed by Chief Commercial Officer Komjathy Andrew

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 443d
  SEC Form 4 filed by Chief Legal Officer Harshbarger Benjamin

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 443d
  SEC Form 4 filed by Chief Financial Officer Clauser Noah

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 443d
  SEC Form 4 filed by Chief Medical Officer Morabito Christopher

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 735d
  SEC Form 4 filed by Lapointe Anthony Gregg

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 735d
  SEC Form 4 filed by Beck Joanne T.

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 735d
  SEC Form 4 filed by Violin Jonathan

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 735d
  SEC Form 4 filed by Callori Fred

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 735d
  SEC Form 4 filed by Kishbauch Michael D

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 735d
  SEC Form 4 filed by Cole Hugh M

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 735d
  SEC Form 4 filed by Bate Kenneth

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 793d
  SEC Form 4 filed by Agarwal Sunil

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 799d
  Morabito Christopher exercised 10,000 shares at a strike of $3.87 and sold $135,939 worth of shares (10,000 units at $13.59) (SEC Form 4)

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 849d
  SEC Form 4 filed by Morabito Christopher

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 849d
  SEC Form 4 filed by Milne Jill C.

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 849d
  SEC Form 4 filed by Matthews Andrea

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 849d
  SEC Form 4 filed by Komjathy Andrew

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 849d
  SEC Form 4 filed by Harshbarger Benjamin

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 849d
  SEC Form 4 filed by Clauser Noah

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 862d
  Morabito Christopher exercised 10,000 shares at a strike of $3.87 and sold $111,364 worth of shares (10,000 units at $11.14) (SEC Form 4)

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Milne Jill C.

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Matthews Andrea

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Komjathy Andrew

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Harshbarger Benjamin

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Kishbauch Michael D

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Lapointe Anthony Gregg

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Violin Jonathan

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Cole Hugh M

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Callori Fred

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Morabito Christopher

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Clauser Noah

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Beck Joanne T.

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1101d
  SEC Form 4 filed by Bate Kenneth

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1149d
  SEC Form 4 filed by Matthews Andrea

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1267d
  SEC Form 4: Perceptive Advisors Llc bought $9,999,998 worth of shares (908,265 units at $11.01)

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)
• 1409d
  SEC Form 4 filed by Morabito Christopher

  4 - Astria Therapeutics, Inc. (0001454789) (Issuer)

Other ATXS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends